Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation
Jasmeet S. Reyat, Winnie Chua, Victor Roth Cardoso, et al.
JCI Insight (2020) Vol. 5, Iss. 16
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
Renate B. Schnabel, Elena Andreassi Marinelli, Elena Arbelo, et al.
EP Europace (2022) Vol. 25, Iss. 1, pp. 6-27
Open Access | Times Cited: 140
Atrial Cardiomyopathy Revisited - Evolution of a Concept. A Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Association (APHRS), and the Latin American Heart Rhythm Society (LAHRS)
Andreas Goette, Domenico Corradi, Dobromir Dobrev, et al.
EP Europace (2024) Vol. 26, Iss. 9
Open Access | Times Cited: 45
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Dominik Linz, Jason G. Andrade, Elena Arbelo, et al.
EP Europace (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 38
Atrial fibrillation burden: a new outcome predictor and therapeutic target
Nina Becher, Andreas Metzner, Tobias Toennis, et al.
European Heart Journal (2024) Vol. 45, Iss. 31, pp. 2824-2838
Open Access | Times Cited: 30
BMP9 and BMP10: Two close vascular quiescence partners that stand out
Agnès Desroches‐Castan, Emmanuelle Tillet, Claire Bouvard, et al.
Developmental Dynamics (2021) Vol. 251, Iss. 1, pp. 158-177
Open Access | Times Cited: 58
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart
Jolanda van der Velden, Folkert W. Asselbergs, Jeroen Bakkers, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 15, pp. 3016-3051
Open Access | Times Cited: 55
Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study
Larissa Fabritz, Christoph Al-Taie, Katrin Borof, et al.
European Heart Journal (2024)
Open Access | Times Cited: 10
Disturbed atrial metabolism, shear stress, and cardiac load AF after ablation: AXAFA biomolecule study
Winnie Chua, Alya Khashaba, Hansel Canagarajah, et al.
EP Europace (2024) Vol. 26, Iss. 2
Open Access | Times Cited: 9
Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets
Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 209-209
Open Access | Times Cited: 9
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation
Ziad Hijazi, Alexander P. Benz, Johan Lindbäck, et al.
European Heart Journal (2022) Vol. 44, Iss. 3, pp. 208-218
Open Access | Times Cited: 30
Insights into bone morphogenetic proteins in cardiovascular diseases
Di Ye, Yinghui Liu, Heng Pan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Bone Morphogenetic Protein 10—A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation
Elisa Hennings, Steffen Blum, Stefanie Aeschbacher, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 6
Open Access | Times Cited: 18
Recurrence After Atrial Fibrillation Ablation and Investigational Biomarkers of Cardiac Remodeling
Majd El‐Harasis, Joseph A. Quintana, Jose Roberto Martinez‐Parachini, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 6
Open Access | Times Cited: 7
PITX2 Knockout Induces Key Findings of Electrical Remodeling as Seen in Persistent Atrial Fibrillation
Carl Schulz, Marc D. Lemoine, Giulia Mearini, et al.
Circulation Arrhythmia and Electrophysiology (2023) Vol. 16, Iss. 3
Open Access | Times Cited: 15
Circulating BMP10 Levels Associate With Late Postoperative Atrial Fibrillation and Left Atrial Endomysial Fibrosis
Joris Winters, Michal Kawczynski, Martijn Gilbers, et al.
JACC. Clinical electrophysiology (2024) Vol. 10, Iss. 7, pp. 1326-1340
Open Access | Times Cited: 6
PITX2 deficiency leads to atrial mitochondrial dysfunction
Jasmeet S. Reyat, Laura C. Sommerfeld, Molly O’Reilly, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 15, pp. 1907-1923
Open Access | Times Cited: 6
Genetics and Pharmacogenetics of Atrial Fibrillation
Asia Owais, Miles Barney, Olivia T Ly, et al.
JACC Basic to Translational Science (2024) Vol. 9, Iss. 7, pp. 918-934
Open Access | Times Cited: 5
Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study
Larissa Fabritz, Winnie Chua, Victor Roth Cardoso, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 8, pp. 855-868
Open Access | Times Cited: 5
Translation of pathophysiological mechanisms of atrial fibrosis into new diagnostic and therapeutic approaches
Ulrich Schotten, Andreas Goette, Sander Verheule
Nature Reviews Cardiology (2024)
Closed Access | Times Cited: 5
Intermittent fasting attenuates obesity-related atrial fibrillation via SIRT3-mediated insulin resistance mitigation
Yudi Zhang, Feng Gao, Haoyu Gong, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 4, pp. 166638-166638
Open Access | Times Cited: 13
Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation
Elisa Hennings, Stefanie Aeschbacher, Michael Coslovsky, et al.
EP Europace (2023) Vol. 25, Iss. 6
Open Access | Times Cited: 11
Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillation
Pascal Meyre, Stefanie Aeschbacher, Steffen Blum, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Rationale and Design of the ISOLATION Study: A Multicenter Prospective Cohort Study Identifying Predictors for Successful Atrial Fibrillation Ablation in an Integrated Clinical Care and Research Pathway
D V M Verhaert, Dominik Linz, Sevasti Maria Chaldoupi, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 17
Blood-Based Biomarkers to Search for Atrial Fibrillation in High-Risk Asymptomatic Individuals and Cryptogenic Stroke Patients
Elena Palà, Alejandro Bustamante, Jorge Pagola, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 17
An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions
Winnie Chua, Victor Roth Cardoso, Eduard Guasch, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top